Cystic Fibrosis clinical trials
98 active trials name this condition. Describe your situation to see which ones you may be eligible for.
Refine by biomarker
By location
- A Study Assessing KB407 for the Treatment of Cystic Fibrosis
- Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of SPL84 in Patients With Cystic Fibrosis
- Safety, Tolerability and Efficacy Study of ARCT-032 in People With Cystic Fibrosis
- Phase 2 Study to Assess the Safety and Efficacy of ANG003
- GERD in Children With Cystic Fibrosis
- Metformin for People With CFRD on CFTR Modulator Therapy to Improve Ion Channel Function
- Bacteriophages for Adults With Cystic Fibrosis and Chronic Achromobacter Lung Infection
- Streamlined Treatment of Pulmonary Exacerbations in Pediatrics
- Maralixibat in Patients With Cystic Fibrosis and Constipation
- Targeting Inflammation With Losartan to Improve Response to Modulator Therapy in Cystic Fibrosis.
- Personalized Theratyping Trial
- Dose Escalation Study Evaluating the Safety and Pharmacokinetics of VX-272 in Healthy Participants
- Assessing Tenapanor as a Treatment of CF-related Constipation.
- The Effects of a Low Glycemic Load Diet on Dysglycemia and Body Composition in Adults With Cystic Fibrosis-Related Diabetes
- Personalized Mobile Health Platform to Promote Physical Activity in Adolescents and Young Adults With Cystic Fibrosis
- 4D-710 in Adult Patients With Cystic Fibrosis
- A Phase 2 Study Evaluating Safety and Tolerability of RCT2100 (CFTR mRNA) in Healthy Participants and in Participants With CF
- CF Wellness Program
- A Phase 1/2 Trial of SP-101 for the Treatment of Cystic Fibrosis (CF)
- Dose Escalation Study Evaluating the Safety and Pharmacokinetics of VX-581 in Healthy Participants
- Testing Drug Efficacy in Cystic Fibrosis Through N-of-1 Trials
- Study With Phage for CF Subjects With Pseudomonas Lung Infection
- IV Gallium Study for Patients With Cystic Fibrosis Who Have NTM (ABATE Study)
- Ensuring Access to Optimal Therapy in CF: The ENACT Study
- Estrogen Supplementation and Bone Health in Women With CF
- Sinonasal Therapies and Histologic Correlations of Patients With Cystic Fibrosis in the Era of Highly Effective Modulator Therapy
- Standardizing Treatments for Pulmonary Exacerbations - Aminoglycoside Study
- ACT With CF Self-Help Toolkit
- FEED-Cystic Fibrosis (FEED-CF)
- BEGIN Novel ImagiNG Biomarkers
- Skin-interfaced Colorimetric Bifluidic Sweat Sensor Device for the Diagnosis of Cystic Fibrosis (CF)
- Regional Monitoring of CF Lung Disease
- Markers of Osteoporosis in Cystic Fibrosis
- Hyperpolarized 129Xe MR Imaging of Lung Function in Healthy Volunteers and Subjects With Pulmonary Disease
- Acoustic Waveform Respiratory Evaluation
- Rare CFTR Mutation Cell Collection Protocol (RARE)
- Study to Enable New Diagnostics for Pulmonary Microbes in People With CF
- TIDES 2.0: Prevalence and Longitudinal Course of Depression, Anxiety, and Behavior Problems in Children With Cystic Fibrosis Under 12 Years of Age
- Remote Sputum Collection in Cystic Fibrosis
- Studying the Presence of CFRD Complications With Thoughtful Recruitment (SPeCTRuM)
- Genetic Risk Factor for Heat Stroke
- Aquagenic Wrinkling Prediction
- Restarting Triple Therapy With Robust Monitoring for Adverse Events (RETRIAL)
- Feasibility of Cough Monitoring in Children
- Continuous Glucose Monitoring and OGTT Screen for Cystic Fibrosis Related Diabetes in Cystic Fibrosis
- Glucose Monitoring in Youth With Cystic Fibrosis During Pulmonary Exacerbations
- A Research Study to Advance the CF Therapeutics Pipeline for People Without Modulators
- Health Outcomes of Parents With Cystic Fibrosis-Aim 2
- Skeletal Health and Bone Marrow Composition in Adolescents With Cystic Fibrosis
- 19F MRI in Healthy Children and Children With Mild Cystic Fibrosis Lung Disease
Guides for people searching for a trial
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.
Showing active trials that list “Cystic Fibrosis” as a condition. Eligibility shown on each trial is an estimate — the trial's study team makes the final decision.